Association of variations in HLA-class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma

被引：0
|
作者：
Shiraishi, Kouya
Okada, Yukinori
Takahashi, Atsushi
Kamatani, Yoichiro
Ashikawa, Kyota
Momozawa, Yukihide
Kunitoh, Hideo
Matsumoto, Shingo
Takano, Atsushi
Shimizu, Kimihiro
Goto, Akiteru
Tsuta, Koji
Watanabe, Shun-ichi
Ohe, Yuichiro
Watanabe, Yukio
Goto, Yasishi
Nokihara, Hiroshi
Furuta, Koh
Yoshida, Akihiko
Goto, Koichi
Hishida, Tomoyuki
Tsuboi, Masahiro
Tsuchihara, Katsuya
Miyagi, Yohei
Nakamura, Haruhiko
Yokose, Tomoyuki
Tanaka, Katsuya
Nagashima, Toshiteru
Ohtaki, Yoichi
Maeda, Daichi
Imai, Kazuhiro
Minamiya, Yoshihiro
Sakamoto, Hiromi
Saito, Akira
Shimada, Yoko
Sunami, Kuniko
Saito, Motonobu
Yoshida, Teruhiko
Yokota, Jun
Matsuda, Fumihiko
Matsuo, Keitaro
Daigo, Yataro
Kubo, Michiaki
Kohno, Takashi
机构：
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2017年 / 26卷 / 05期
关键词：
D O I：
10.1158/1538-7755.CARISK16-B25
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B25
引用
收藏
页数：2
相关论文
共 50 条
  • [41] EGFR-mutated lung adenocarcinoma with choroidal oligometastasis during treatment with gefitinib: a case report
    Hashimoto, Takafumi
    Osoegawa, Atsushi
    Abe, Miyuki
    Oki, Ryoko
    Karashima, Takashi
    Takumi, Yohei
    Kamada, Kosuke
    Miyawaki, Michiyo
    Sugio, Kenji
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2024, 13 (03) : 204 - 208
  • [42] Breast metastasis from EGFR-mutated lung adenocarcinoma: A case report and review of the literature
    Ota, Takayo
    Hasegawa, Yoshikazu
    Okimura, Akira
    Sakashita, Katsuya
    Sunami, Takeshi
    Yukimoto, Kiyotaka
    Sawada, Ryugo
    Sakamoto, Kazutsugu
    Fukuoka, Masahiro
    CLINICAL CASE REPORTS, 2018, 6 (08): : 1510 - 1516
  • [43] First-Line Management of EGFR-Mutated Advanced Lung Adenocarcinoma: Recent Developments
    Liao, Bin-Chi
    Lin, Chia-Chi
    Yang, James Chih-Hsin
    DRUGS, 2013, 73 (04) : 357 - 369
  • [44] Comparison of Thoracic Radiotherapy Efficacy Between Patients With and Without EGFR-mutated Lung Adenocarcinoma
    Li, Ming-Hsien
    Tsai, Jo-Ting
    Ting, Lai-Lei
    Lin, Jang-Chun
    Liu, Yu-Chang
    IN VIVO, 2018, 32 (01): : 203 - 209
  • [45] Afatinib in Treatment-Naive Patients With EGFR-Mutated Lung Adenocarcinoma With Brain Metastasis
    Li, Shih-Hong
    Hsieh, Meng-Heng
    Fang, Yueh-Fu
    MEDICINE, 2015, 94 (41)
  • [46] Epidermal Growth Factor Receptor ( EGFR) Signaling Regulates Global Metabolic Pathways in EGFR-mutated Lung Adenocarcinoma
    Makinoshima, Hideki
    Takita, Masahiro
    Matsumoto, Shingo
    Yagishita, Atsushi
    Owada, Satoshi
    Esumi, Hiroyasu
    Tsuchihara, Katsuya
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (30) : 20813 - 20823
  • [47] EGFR Inhibitors Combined with Intrathoracic Perfusion Manages Malignant Pleural Effusion in EGFR-Mutated Metastatic Lung Adenocarcinoma
    Huang, W.
    Liao, S.
    Lei, X.
    Chen, Z.
    Xu, K.
    Wang, Y. -F.
    Zhou, Q.
    Liu, J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S627 - S628
  • [48] Association between HLA-Class I and HLA-Class II Alleles and Mycobacterium Tuberculosis Infection in Iraqi Patients from Baghdad City
    Mohammed, Nidhal
    Qassem, Haitham
    Hassen, Farouk
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2014, 39 (02) : 191 - 195
  • [49] The Association of HLA-Class I and Class II with Hodgkin's Lymphoma in Iranian Patients
    Sayad, Arezou
    Akbari, Mohammad Taghi
    Mehdizadeh, Mahshid
    Movafagh, Abolfazl
    Hajifathali, Abbas
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [50] Combining EGFR and MET Inhibition With Crizotinib in EGFR-mutated Lung Adenocarcinoma Harboring MET Amplification: A Brief Report
    Aubanel, Marjorie
    Swalduz, Aurelie
    Avrillon, Virginie
    Doublet, Louis
    Mastroianni, Benedicte
    Neidhardt-Berard, Eve-Marie
    Perol, Maurice
    CLINICAL LUNG CANCER, 2020, 21 (06) : E601 - E606
12345